With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
HCA trades against a final fair-value range of $496.77-$798.49, with the midpoint set by the accepted valuation synthesis rather than earlier draft model outputs.
A prolonged period of elevated interest rates combined with flat commercial volumes and margin compression to 13% would severely stress HCA's free cash flowFree cash flowOperating cash flow minus capital expenditures. The cash a business generates after maintaining and growing its asset base — the closest accounting proxy for owner-economics., threatening the heavily leveraged capital structure and ending the share repurchase algorithm.
Government payers drastically compress Medicare/Medicaid rates to manage ballooning deficits, crushing margins.
Persistent clinical staff shortages force a permanent reliance on expensive contract labor, eroding operating margins below 14%.
Refinancing the massive $48.7B net debt load at significantly higher rates extinguishes the aggressive buyback program.
| Line item | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
|---|---|---|---|---|---|---|
| Revenue | — | $60.23B | $64.97B+7.9% | $70.60B+8.7% | $75.60B+7.1% | +5.8% |
| Gross profit | — | $23.18B | $25.58B | $28.68B | $31.37B | +7.9% |
| Operating income | — | $9.05B | $9.63B | $10.55B | $11.97B | +7.2% |
| Net income | — | $5.64B | $5.24B-7.1% | $5.76B+9.9% | $6.78B+17.7% | +4.7% |
| EPS (diluted) | — | $19.15 | $18.97 | $22.00 | $28.33 | +10.3% |
| EBITDA | — | $13.29B | $12.72B | $13.90B | $15.60B | +4.1% |
| R&D | — | — | — | — | — | — |
| SG&A | $26.78B | $27.69B | $29.49B | $31.17B | — | +3.9% |
Cash-flow quality is reflected in the OCFOperating cash flowCash generated from the company's core operations after working-capital changes but before capital expenditures. The first line of the cash-flow statement. / net incomeNet IncomeNet Income is an income-statement line item used to reconcile revenue to operating profit, pre-tax income, net income, or per-share earnings. It should be compared across periods and against peer disclosure conventions., accounting-quality, and ROICROICReturn on invested capital. Operating profit (after tax) divided by invested capital. The single best gauge of capital-efficiency. Spread over WACC = economic value created. rows above.
Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.
| Deterioration versus the report thesis |
| Negative shift in payer mix toward government and uninsured. | Monitor | Deterioration versus the report thesis |
| Deterioration of free cash flow conversion below $7B annually. | Monitor | Deterioration versus the report thesis |
